FDA to Reclassify CES

FDA to Reclassify CES

The Food and Drug Administration (FDA) has agreed to propose approval and reclassification of cranial electrotherapy stimulation (CES) devices for the treatment of insomnia, depression, and anxiety. In a document to be published tomorrow, the FDA says it is...